Your session is about to expire
← Back to Search
Enrollees for Genetic Disorder
Study Summary
This trial aims to test a new method, called BeginNGS, for screening newborns using whole genome sequencing at Rady Children's Hospital in San Diego. They want to see how effective this method
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any ongoing efforts to enlist participants for this trial?
"Indeed, the information on clinicaltrials.gov confirms that this trial is actively enrolling participants. The trial was first listed on March 13, 2023 and most recently revised on February 16, 2024. They are seeking to recruit a total of 200 patients at a single site."
What is the overall count of individuals involved in this research endeavor?
"Indeed, the information on clinicaltrials.gov reflects that this particular medical investigation is presently seeking eligible participants. The trial was first made available on March 13th, 2023, with the most recent update recorded on February 16th, 2024. A total of 200 individuals are sought after for inclusion from a single designated site."
What are the eligibility criteria for individuals interested in participating in this research project?
"Individuals eligible for inclusion in this research must exhibit a genetic anomaly and be between 24 hours and 240 hours old. The study aims to recruit a cohort of 200 participants."
Is the clinical trial open to participants who are under the age of 18?
"Individuals as young as 24 hours old and up to 240 hours old are eligible for enrollment based on the inclusion criteria of this trial."
Share this study with friends
Copy Link
Messenger